Cline Scientific AB (OSTO:CLINE B) EBIT : kr-3.11 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Cline Scientific AB EBIT?

Cline Scientific AB's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was kr0.24 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was kr-3.11 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cline Scientific AB's annualized ROC % for the quarter that ended in Dec. 2023 was 2.71%. Cline Scientific AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 1,882.35%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cline Scientific AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 1,279.42%.

Cline Scientific AB EBIT Historical Data

The historical data trend for Cline Scientific AB's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cline Scientific AB EBIT Chart

Cline Scientific AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

-1.78

-1.65

-3.50

-2.32

-3.11

Cline Scientific AB Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial												-0.14	-2.55	0.24	-3.35	0.24

Competitive Comparison of Cline Scientific AB's EBIT

For the Biotechnology subindustry, Cline Scientific AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cline Scientific AB's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cline Scientific AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cline Scientific AB's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Cline Scientific AB EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-3.11 Mil.

Cline Scientific AB (OSTO:CLINE B) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cline Scientific AB's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	0.48 * ( 1 - 0% )	/	( (14.555	+	20.83)	/ 2 )
=	0.48	/	17.6925
=	2.71 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	14.974	-	0.334	-	( 0.085	-	max(0, 0.065	-	0.163	+	0.085	))
=	14.555

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	22.721	-	0.241	-	( 3.349	-	max(0, 1.804	-	3.454	+	3.349	))
=	20.83

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Cline Scientific AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	0.48	/	( ( (0.029 + max(-0.065, 0))	+	(0.022 + max(-1.804, 0)) )	/	2 )
=	0.48	/	( ( 0.029	+	0.022 )	/	2 )
=	0.48	/	0.0255
=	1,882.35 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0.334	+	0	+	-0.269)
=	-0.065

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0.241	+	0	+	1.563)
=	-1.804

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cline Scientific AB's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	-3.109	/	-0.243
	=	1,279.42 %

Cline Scientific AB EBIT Related Terms

Thank you for viewing the detailed overview of Cline Scientific AB's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Cline Scientific AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cline Scientific AB (OSTO:CLINE B) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Vastra Gotalands Lan, 2C Argongatan, Molndal, SWE, 43153

Website

https://www.clinescientific.com

Cline Scientific AB develops and markets products for biomedical research based on proprietary nanotechnology. Its products include unique surfaces for use in stem cell & cancer research and customized nanoparticles for use in biomedical applications.

Cline Scientific AB Headlines

No Headlines